ADT Does Not Raise Risk of Heart Attacks In Men With No History Of Heart Disease
Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint
MDV3100 Improves Survival, Reduces Death Risk by 37%
Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication
Elevated Baseline Glucose Levels Associated With Higher Cancer Risk
Oncotype DX Cancer Test Can Predict Recurrence
Signet Cell A Rising Trend In Patients Under Age 40
FIT More Effective Than gFOBT In All Colonoscopy Capacities
Tumor Treating Fields Therapy Increased Three-Year Survival
Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy
New Algorithm Completes Scan Three Times Faster Than Before
Survivorship Studies Unfocused As Total Research Increases
Trials Approved by NCI CTEP Last Month
Agency Approves HPV Test That Detects 14 High-Risk Strains
Alimta Granted Approval As NSCLC Continuation Therapy
Trending Stories
- With five-year cancer survival at an all-time high, does this mean people are living longer?
- House passes three-year extension of ACA subsidies with bipartisan support
- When “safe and effective” is not “reasonable and necessary”
We can curb excessive drug dosing and improve the quality of cancer care - Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- The Mark Foundation names 2026 Emerging Leader Award recipients
- A radiation oncologist’s perspective: Why we need to accelerate early detection strategies for lung cancers
